Natural ways to prevent hair loss during chemotherapy is a question many patients ask when facing treatment. Chemotherapy-induced alopecia is one of the most emotionally challenging side effects of cancer care, affecting the scalp, eyebrows, eyelashes, and body hair. While the desire to explore supportive and natural options is entirely understandable, it is essential to distinguish between evidence-based interventions and unproven remedies. This article outlines what the clinical evidence currently supports, including scalp cooling, gentle hair care, and nutritional wellbeing, alongside clear guidance on when to seek advice from your oncology team.

Why Chemotherapy Causes Hair Loss

Chemotherapy damages hair follicles because follicle cells divide rapidly, making them vulnerable to cytotoxic drugs; hair loss typically begins two to four weeks after treatment starts and usually regrows within three to six months of completing chemotherapy.

Not sure if this is normal? Chat with one of our pharmacists →

Hair loss (alopecia) is one of the most emotionally significant side effects of chemotherapy, affecting a large proportion of patients undergoing treatment. Understanding why it happens can help patients feel more prepared and empowered to explore supportive options.

Chemotherapy drugs work by targeting rapidly dividing cells — a defining characteristic of cancer cells. However, hair follicle cells are among the fastest-dividing cells in the human body, which makes them particularly vulnerable to the same cytotoxic mechanisms. Drugs such as doxorubicin, cyclophosphamide, paclitaxel, and docetaxel are especially associated with significant hair loss, though the degree varies depending on the drug, dose, and individual patient factors.

Hair loss typically begins within two to four weeks of starting treatment and may affect the scalp, eyebrows, eyelashes, and body hair. In most cases, hair regrowth begins within three to six months after chemotherapy ends, though the timing and degree of regrowth vary between individuals, and texture or colour may temporarily differ. In rare cases, hair loss may be prolonged — a condition known as persistent chemotherapy-induced alopecia (pCIA), which is discussed further below.

It is important to note that not all chemotherapy regimens cause hair loss. However, some targeted therapies — for example, EGFR inhibitors — can cause hair and skin changes, and some endocrine (hormonal) therapies may cause hair thinning. Your oncology team will be able to advise on what to expect based on your specific treatment plan. Further information is available from the NHS and Macmillan Cancer Support.

What the Evidence Says About Natural Approaches

No natural remedy, herbal supplement, or topical treatment has robust clinical evidence supporting its ability to prevent chemotherapy-induced hair loss, and some supplements can interact dangerously with chemotherapy drugs.

Many patients understandably seek natural ways to prevent hair loss during chemotherapy, and it is important to approach this topic with both compassion and clinical honesty. Currently, there is no robust clinical evidence that any natural remedy, herbal supplement, or topical treatment can reliably prevent chemotherapy-induced alopecia.

Minoxidil is a topical treatment licensed in the UK for androgenetic alopecia (pattern hair loss). Some small studies have explored its use to accelerate regrowth after chemotherapy, but this represents an off-label use and its role in prevention remains limited. Patients should discuss this with their oncologist or dermatologist before considering it.

Herbal preparations such as rosemary oil, peppermint oil, and saw palmetto are sometimes discussed online, but there is no reliable evidence linking these remedies to the prevention of chemotherapy-related hair loss. Evidence supporting their use in this specific context is either absent or of very low quality. It is also worth noting that topical essential oils and other preparations can irritate sensitive or compromised scalp skin during treatment and should generally be avoided unless a clinician advises otherwise.

Some supplements — including high-dose biotin, St John's Wort, and certain antioxidants — may interact with chemotherapy drugs. The MHRA has issued specific safety guidance on St John's Wort due to its extensive interactions with a wide range of medicines, and the BNF lists numerous clinically significant herb–drug interactions. Evidence on whether high-dose antioxidants reduce chemotherapy effectiveness is mixed and varies by regimen, but the potential risk means caution is warranted. Before taking any supplement or herbal product during cancer treatment, patients should always consult their oncologist or a pharmacist with oncology experience. The NHS also advises caution with unlicensed herbal products, particularly those purchased online, during active cancer treatment.

Worried about interactions with other medications? Speak to one of our pharmacists →

Patients should also be aware that suspected side effects from medicines, or problems with medical devices used during treatment, can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app. Focusing on evidence-based supportive care, rather than unproven remedies, remains the safest and most effective approach.

Scalp Cooling: An NHS-Supported Option Worth Knowing

Scalp cooling is the most evidence-supported intervention for reducing chemotherapy-induced hair loss and is available through many NHS trusts, though it is not suitable for all patients or all chemotherapy regimens.

Scalp cooling — also known as cold capping — is currently the most evidence-supported intervention for reducing chemotherapy-induced hair loss, and it is available through many NHS trusts. While not strictly a 'natural' remedy, it is a non-pharmacological, physical intervention that works without the use of drugs or chemicals.

Scalp cooling works by constricting blood vessels in the scalp during chemotherapy infusion, thereby reducing the amount of cytotoxic drug that reaches the hair follicles. It also slows follicle cell metabolism, making them less vulnerable to the drug's effects. Evidence from clinical trials and Cochrane systematic reviews has demonstrated that scalp cooling can meaningfully reduce hair loss in patients receiving certain chemotherapy regimens — particularly those used in breast cancer treatment. NHS guidance and Macmillan Cancer Support both recognise scalp cooling as a supportive care option.

Effectiveness varies depending on the chemotherapy drugs used, the dose, and individual factors. It is generally less effective with regimens that include anthracyclines at higher doses. Scalp cooling also requires additional time before and after each infusion, and correct cap sizing and fit are important for efficacy — your clinical team will advise on this.

Scalp cooling is not suitable for all patients. It is generally not recommended for those with haematological cancers (such as leukaemia or lymphoma), or for patients with cold-sensitivity conditions including cold agglutinin disease, cryoglobulinaemia, or cold urticaria. There is also a rare and theoretical concern about the risk of scalp metastases, which your oncology team will discuss with you as part of an individual risk–benefit assessment. Side effects are generally mild and may include headache, coldness, or discomfort during the session.

Patients interested in scalp cooling should raise this with their oncology team as early as possible — ideally before treatment begins — as it must be arranged in advance. Many cancer centres now offer this as a standard supportive care option. Any problems experienced with scalp cooling devices should be reported via the MHRA Yellow Card scheme.

Gentle Hair and Scalp Care During Treatment

Using mild, fragrance-free products, avoiding heat styling, and protecting the scalp from sun exposure can reduce discomfort and protect fragile hair during chemotherapy, though these measures cannot prevent hair loss entirely.

While it may not be possible to prevent hair loss entirely, adopting a gentle hair and scalp care routine can help protect fragile hair, reduce discomfort, and support scalp health throughout chemotherapy.

Practical tips for hair and scalp care during treatment include:

• Use mild, fragrance-free shampoos and conditioners to minimise scalp irritation

• Wash hair with lukewarm (not hot) water and pat dry gently with a soft towel — avoid vigorous rubbing

• Avoid heat styling tools such as hairdryers, straighteners, and curling tongs, which can weaken already fragile hair shafts

• Limit the use of chemical treatments such as colouring, bleaching, or perming during and immediately after chemotherapy

• Use a wide-toothed comb rather than a brush, and comb gently to reduce mechanical stress on the hair

• Consider cutting hair shorter before treatment begins, as shorter hair can feel lighter and may make the transition easier emotionally

For patients who experience complete hair loss, keeping the scalp moisturised with a gentle, unfragranced lotion can help prevent dryness and discomfort. Wearing soft cotton head coverings at night can protect a sensitive scalp during sleep. It is also important to protect the scalp from sun exposure — wearing a hat, scarf, or applying a broad-spectrum SPF 30 or higher sunscreen to exposed areas is advisable when outdoors.

The NHS provides access to wigs through some cancer services, though availability and any associated charges vary across the UK. Your clinical nurse specialist or oncology team can advise on local eligibility and what support is available in your area. Further practical guidance is available from Macmillan Cancer Support.

Nutrition and Lifestyle Support During Chemotherapy

Adequate protein intake, a balanced diet, and good hydration support overall resilience and eventual hair regrowth, but no specific food or supplement has been proven to prevent chemotherapy-induced alopecia.

Good nutrition and general wellbeing play an important role in supporting the body during chemotherapy, and while they cannot prevent treatment-related hair loss, they may support overall resilience and recovery — including the eventual regrowth of hair.

Adequate protein intake is particularly important, as hair is primarily composed of keratin, a structural protein. Ensuring sufficient dietary protein from sources such as lean meat, fish, eggs, dairy, legumes, and nuts can support the body's capacity for tissue repair and regeneration. Iron deficiency is also associated with hair thinning, and chemotherapy can sometimes affect nutritional absorption. Blood tests to check iron, ferritin, vitamin B12, and vitamin D levels may be arranged if clinically indicated — for example, if symptoms suggest a deficiency — but these are not automatically part of routine monitoring for all patients. If you have concerns about nutritional deficiencies, discuss these with your oncology team.

General lifestyle measures that may support wellbeing during treatment include:

• Eating a balanced, varied diet in line with NHS Eatwell Guide principles

• Staying well hydrated, aiming for six to eight glasses of fluid per day

• Engaging in gentle physical activity, such as walking or yoga, as tolerated and approved by your clinical team

• Prioritising sleep and stress management, as chronic stress can exacerbate hair shedding

There is no specific 'superfood' or supplement proven to prevent chemotherapy-induced alopecia. Patients should avoid high-dose vitamin or mineral supplements unless specifically recommended by their oncology team, as some may interfere with treatment. A referral to an oncology dietitian can be invaluable for personalised nutritional guidance. Macmillan Cancer Support also provides helpful information on diet during cancer treatment.

When to Speak to Your Oncology Team About Hair Loss

Seek urgent medical advice if you develop a temperature of 38°C or above or signs of scalp infection; contact your oncology team if hair loss persists beyond six months after treatment or if you experience significant psychological distress.

Hair loss during chemotherapy is expected and, in most cases, temporary. However, there are circumstances in which it is important to raise concerns with your oncology team or clinical nurse specialist rather than managing the situation alone.

Seek urgent medical advice immediately — via your oncology unit's 24-hour emergency contact number, or NHS 111 if you cannot reach them — if you experience:

• A temperature of 38°C or above, or feel generally unwell with signs of possible infection, as this may indicate neutropenic sepsis, which requires prompt assessment

• Scalp blistering or signs of skin infection, particularly if you are using a cold cap

Contact your oncology team if you experience any of the following:

• Scalp pain, redness, or persistent discomfort, particularly in association with scalp cooling

• Significant psychological distress related to hair loss that is affecting your daily functioning or mental health — your GP can also provide support if your oncology team is not immediately available

• Hair loss that appears to be worsening in an unexpected pattern, or that continues long after chemotherapy has ended

• Concerns about whether a supplement or natural remedy you are considering is safe to use alongside your treatment

It is also worth discussing hair loss proactively before treatment begins. Many cancer centres offer pre-treatment consultations with specialist nurses who can explain what to expect, provide information on scalp cooling, and signpost patients to wig services and support groups. Organisations such as Macmillan Cancer Support and Alopecia UK offer practical guidance and emotional support for those affected.

If hair regrowth has not begun within approximately six months of completing chemotherapy, or if regrowth appears significantly abnormal, this should be discussed with your oncologist. In rare cases, persistent chemotherapy-induced alopecia (pCIA) can occur, and specialist dermatological assessment may be appropriate. Open communication with your clinical team remains the most important step in managing hair loss safely and effectively throughout your cancer journey.

Any suspected side effects from medicines or problems with medical devices used during your treatment can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.

Frequently Asked Questions